4.7 Review

Pharmacogenomic insights into treatment and management of statin-induced myopathy

期刊

GENOME MEDICINE
卷 1, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/gm120

关键词

-

资金

  1. GlaxoSmithKline
  2. Novo Nordisk
  3. Dutch Medicines Evaluation Board
  4. Dutch Ministry of Health

向作者/读者索取更多资源

Although statins are generally well tolerated, the most common adverse drug reaction from statin therapy is myopathy. This article reviews the current pharmacogenomic knowledge of statin-induced myopathy. Furthermore, we will discuss the importance of recent pharmacogenetic advances for the treatment and management of statin-induced myopathy. Variation in the SLCO1B1 gene is associated with increased incidence of statin-induced myopathy, particularly with simvastatin and less so with other statins. If different pharmacokinetic enzymes and transporters are responsible for susceptibility to myopathy, this may explain differences in the occurrence of statin-induced myopathy in individual patients. Genotyping in patients suffering from statin-induced myopathy may help to personalize the choice of statin for the lowest chance of developing myopathy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 months

Mahmoud Abdel-Aziz, Paul Brinkman, Susanne J. H. Vijverberg, Anne H. Neerincx, John H. Riley, Stewart Bates, Simone Hashimoto, Nazanin Zounemat Kermani, Kian Fan Chung, Ratko Djukanovic, Sven-Erik Dahlen, Ian M. Adcock, Peter H. Howarth, Peter J. Sterk, Aletta D. Kraneveld, Anke H. Maitland-van der Zee

Summary: Two distinct severe asthma phenotypes were identified based on sputum microbiome profiles, showing relative stability over 12 to 18 months. Further validation with an independent cohort of patients with mild-to-moderate asthma confirmed the robustness and consistency of the clustering assignments.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Allergy

Treating severe asthma: Targeting the IL-5 pathway

Stefania Principe, Celeste Porsbjerg, Sisse Bolm Ditlev, Ditte Kjaersgaard Klein, Korneliusz Golebski, Nanna Dyhre-Petersen, Yoni E. van Dijk, Job J. M. H. van Bragt, Lente L. H. Dankelman, Sven-Erik Dahlen, Christopher E. Brightling, Susanne J. H. Vijverberg, Anke H. Maitland-van der Zee

Summary: Severe asthma is heterogeneous, with the eosinophilic phenotype being effectively treated by monoclonal antibodies targeting the eosinophilic inflammatory pathways. Apart from the eosinophil threshold, markers like improved asthma symptoms, lung function, and decreased exacerbations are indicative of treatment response.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Review Oncology

Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis

Hedy Maagdenberg, Natanja Oosterom, Jolanda Zanen, Donato Gemmati, Rachael E. Windsor, Sandra G. Heil, Patricia Esperon, Shakila Jabeen, Guillermo J. Ruiz-Arguelles, Oliver Zolk, Susanne Hoerning, Charlotte Sleurs, Elixabet Lopez-Lopez, Monica Moreno-Galvan, Marry M. van den Heuvel-Eibrink, Anke H. van der Zee, Bruce C. Carleton

Summary: Methotrexate-induced mucositis varies greatly among individuals, and genetic variants such as MTHFR c.677C > T and MTRR c.66A > G have been found to have statistically significant associations with the occurrence of mucositis. Further research in this area may help in predicting and managing this common side effect of MTX treatment.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Allergy

Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma

Yusef Eamon Badi, Ana B. Pavel, Stelios Pavlidis, John H. Riley, Stewart Bates, Nazanin Zounemat Kermani, Richard Knowles, Johan Kolmert, Craig E. Wheelock, Sally Worsley, Mohib Uddin, Kjell Alving, Per S. Bakke, Annelie Behndig, Massimo Caruso, Pascal Chanez, Louise J. Fleming, Stephen J. Fowler, Urs Frey, Peter Howarth, Ildiko Horvath, Norbert Krug, Anke H. Maitland-van der Zee, Paolo Montuschi, Graham Roberts, Marek Sanak, Dominick E. Shaw, Florian Singer, Peter J. Sterk, Ratko Djukanovic, Sven-Eric Dahlen, Yi-Ke Guo, Kian Fan Chung, Emma Guttman-Yassky, Ian M. Adcock

Summary: The disease signature identified in atopic dermatitis (AD) can also be seen in adults with severe asthma, and the transcriptomic signature of AD patients who respond to anti-IL-22 therapy is enriched in severe asthma. The AD disease signature is enriched in the blood and sputum of patients with asthma and is correlated with the severity of asthma. The FZ-response signature is enriched in the blood and sputum of asthmatic patients and is correlated with the presence of neutrophils and mixed granulocytes in the sputum.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Respiratory System

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients

Renate Kos, Paul Brinkman, Anne H. Neerincx, Tamara Paff, Marije G. Gerritsen, Ariana Lammers, Aletta D. Kraneveld, Harry G. M. Heijerman, Hettie M. Janssens, Jane C. Davies, Christof J. Majoor, Els J. Weersink, Peter J. Sterk, Eric G. Haarman, Lieuwe D. Bos, Anke H. Maitland-van der Zee

Summary: Targeted analysis of volatile organic compounds in exhaled breath can non-invasively identify patients with Pseudomonas aeruginosa in cystic fibrosis, with high accuracy. This provides a new approach for simplifying the diagnosis and monitoring of respiratory infections.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Respiratory System

Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis

Dominic Fenn, Mahmoud Abdel-Aziz, Paul Brinkman, Renate Kos, Anne H. Neerincx, Josje Altenburg, E. Weersink, Eric G. Haarman, Suzanne W. J. Terheggen-Lagro, Anke H. Maitland-van der Zee, Lieuwe D. J. Bos

Summary: Culture-independent analysis of cough swabs provides an inaccurate diagnosis of lower respiratory tract colonisation and should not be used as a diagnostic test in patients with CF.

JOURNAL OF CYSTIC FIBROSIS (2022)

Letter Allergy

Prediction of asthma in early preschool wheezing by electronic nose analysis

Niels Rutjes, Ivo van den Bongaardt, Simone Hashimoto, Peter Sterk, Wim Van Aalderen, Suzanne Terheggen-Lagro, Paul Brinkman, Anke-Hilse Maitland - van der Zee, Marc van der Schee, Eric Haarman

PEDIATRIC ALLERGY AND IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations

Job J. M. H. van Bragt, Stefania Principe, Simone Hashimoto, D. Naomi Versteeg, Paul Brinkman, Susanne J. H. Vijverberg, Els J. M. Weersink, Nicola Scichilone, Anke H. van der Zee

Summary: Exhaled breath analysis using eNose can accurately identify asthma patients who recently had exacerbations, indicating a specific exhaled breath pattern associated with asthma exacerbations.

METABOLITES (2021)

Article Health Care Sciences & Services

Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study

Zulfan Zazuli, Corine de Jong, Wei Xu, Susanne J. H. Vijverberg, Rosalinde Masereeuw, Devalben Patel, Maryam Mirshams, Khaleeq Khan, Dangxiao Cheng, Bayardo Ordonez-Perez, Shao Hui Huang, Anna Spreafico, Aaron R. Hansen, David P. Goldstein, John R. de Almeida, Scott V. Bratman, Andrew Hope, Jennifer J. Knox, Rebecca K. S. Wong, Gail E. Darling, Abhijat Kitchlu, Simone W. A. van Haarlem, Femke van der Meer, Anne S. R. van Lindert, Alexandra ten Heuvel, Jan Brouwer, Colin J. D. Ross, Bruce C. Carleton, Toine C. G. Egberts, Gerarda J. M. Herder, Vera H. M. Deneer, Anke H. Maitland-van der Zee, Geoffrey Liu

Summary: This study identified a specific variant of the BACH2 gene that may play an important role in cisplatin-induced nephrotoxicity, suggesting opportunities for mechanistic research, tailored therapy, and preventive strategies related to this pathology.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Letter Allergy

Migration and allergic diseases: Findings from a population-based study in adults in Amsterdam, the Netherlands

Abena S. Amoah, Maria Prins, Elisabeth H. D. Bel, Wytske J. Fokkens, Aeilko H. Zwinderman, Maria Yazdanbakhsh, Anke H. Maitland-van der Zee, Ronald van Ree

ALLERGY (2022)

Review Health Care Sciences & Services

A Systematic Review of Chest Imaging Findings in Long COVID Patients

Somayeh Bazdar, Anastasia K. A. L. Kwee, Laura Houweling, Yolanda de Wit-van Wijck, Firdaus A. A. Mohamed Hoesein, George S. Downward, Esther J. Nossent, Anke H. Maitland-van der Zee

Summary: Long COVID refers to the persistence of COVID-19 symptoms after the initial infection, and it is associated with lung damage. This systematic review focuses on lung imaging and its findings in patients with long COVID. The study identified 31 articles that reported imaging findings of 342 long COVID patients, with computed tomography (CT) being the most common modality used. Various types of lung abnormalities were observed, but a significant proportion of patients had normal CT findings. Further research is needed to understand the role of lung and organ damage in long COVID.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Biochemistry & Molecular Biology

Analysis of Volatile Organic Compounds in Exhaled Breath Following a COMEX-30 Treatment Table

Feiko J. M. de Jong, Thijs T. Wingelaar, Paul Brinkman, Pieter-Jan A. M. van Ooij, Anke H. van der Zee, Markus W. Hollmann, Rob A. van Hulst

Summary: The study assessed whether VOCs in exhaled breath after COMEX-30 treatment are early markers of hyperoxic stress and/or POT. Results showed that the identified VOCs are associated with inflammatory responses or pulmonary diseases and most subjects reported pulmonary symptoms reflecting early-stage POT. Therefore, these VOCs are likely markers of POT, not just indicators of hyperbaric hyperoxic exposure.

METABOLITES (2023)

Article Biochemistry & Molecular Biology

Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma

Mario Martin-Almeida, Javier Perez-Garcia, Esther Herrera-Luis, Carlos Rosa-Baez, Mario Gorenjak, Anne H. Neerincx, Olaia Sardon-Prado, Antoaneta A. Toncheva, Susanne Harner, Christine Wolff, Susanne Brandstetter, Elisa Valletta, Mahmoud Abdel-Aziz, Simone Hashimoto, Vojko Berce, Paula Corcuera-Elosegui, Javier Korta-Murua, Heike Buntrock-Doepke, Susanne J. H. Vijverberg, Joris C. Verster, Nikki Kerssemakers, Anna M. Hedman, Catarina Almqvist, Jesus Villar, Aletta D. Kraneveld, Uros Potocnik, Michael Kabesch, Anke H. Maitland-van der Zee, Maria Pino-Yanes

Summary: Asthma is a common chronic disease in children, but the influence of DNA methylation on bronchodilator drug response and fractional exhaled nitric oxide is understudied. In this study, we identified DNA methylation markers associated with fractional exhaled nitric oxide in blood samples and bronchodilator drug response in pediatric asthma patients.

BIOMEDICINES (2023)

Article Allergy

Inflammatory innate lymphoid cells predict response speed to dupilumab in chronic rhinosinusitis with nasal polyps

Korneliusz Golebski, Rik Johannes Leonardus van Der Lans, Danielle van Egmond, Esther de Groot, Hergen Spits, Anke-Hilse Maitland-van Der Zee, Cornelis Maria van Drunen, Wytske Johanna Fokkens, Sietze Reitsma

ALLERGY (2023)

Article Health Care Sciences & Services

Precision Medicine for More Oxygen (P4O2)-Study Design and First Results of the Long COVID-19 Extension

Nadia Baalbaki, Jelle M. Blankestijn, Mahmoud I. Abdel-Aziz, Jan de Backer, Somayeh Bazdar, Ines Beekers, Rosanne J. H. C. G. Beijers, Joop P. van den Bergh, Lizan D. Bloemsma, Harm Jan Bogaard, Job J. M. H. van Bragt, Vera van den Brink, Jean Paul Charbonnier, Merel E. B. Cornelissen, Yennece Dagelet, Elin Haf Davies, Anne M. van der Does, George S. Downward, Cornelis M. van Drunen, Debbie Gach, J. J. Miranda Geelhoed, Jorrit Glastra, Kornel Golebski, Irene H. Heijink, Judith C. S. Holtjer, Sebastiaan Holverda, Laura Houweling, John J. L. Jacobs, Renee Jonker, Renate Kos, Ramon C. J. Langen, Ivo van der Lee, Asabi Leliveld, Firdaus A. A. Mohamed Hoesein, Anne H. Neerincx, Lieke Noij, Johan Olsson, Marianne van de Pol, Simon D. Pouwels, Emiel Rolink, Michael Rutgers, Havva Sahin, Daphne Schaminee, Annemie M. W. J. Schols, Lisanne Schuurman, Gitte Slingers, Olie Smeenk, Brigitte Sondermeijer, Paul J. Skipp, Marisca Tamarit, Inge Verkouter, Roel Vermeulen, Rianne de Vries, Els J. M. Weersink, Marco van de Werken, Yolanda de Wit-van Wijck, Stewart Young, Esther J. Nossent, Anke H. van der Zee

Summary: The P4O2 COVID-19 study aims to identify long COVID patients at risk for developing chronic lung disease and to find personalized therapeutic strategies. The study showed persistent symptoms and abnormalities in post-COVID patients, with the most commonly reported symptoms being respiratory and neurological symptoms.

JOURNAL OF PERSONALIZED MEDICINE (2023)

暂无数据